CN105087570B - 一种环状rna人工过表达框架及其表达载体及构建方法 - Google Patents
一种环状rna人工过表达框架及其表达载体及构建方法 Download PDFInfo
- Publication number
- CN105087570B CN105087570B CN201510566302.XA CN201510566302A CN105087570B CN 105087570 B CN105087570 B CN 105087570B CN 201510566302 A CN201510566302 A CN 201510566302A CN 105087570 B CN105087570 B CN 105087570B
- Authority
- CN
- China
- Prior art keywords
- sequence
- circular rna
- framework
- pcr
- process lan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108091028075 Circular RNA Proteins 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 63
- 238000010276 construction Methods 0.000 title claims description 8
- 239000013604 expression vector Substances 0.000 title claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 16
- 239000002773 nucleotide Substances 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims description 29
- 108090000623 proteins and genes Proteins 0.000 claims description 25
- 238000011144 upstream manufacturing Methods 0.000 claims description 20
- 108091008146 restriction endonucleases Proteins 0.000 claims description 19
- 238000012408 PCR amplification Methods 0.000 claims description 15
- 230000014509 gene expression Effects 0.000 claims description 15
- 238000004925 denaturation Methods 0.000 claims description 14
- 230000036425 denaturation Effects 0.000 claims description 14
- 230000003321 amplification Effects 0.000 claims description 13
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 13
- 238000013461 design Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 9
- 230000004087 circulation Effects 0.000 claims description 8
- 238000000137 annealing Methods 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 3
- 239000013600 plasmid vector Substances 0.000 claims description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108010085238 Actins Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 102000007469 Actins Human genes 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 101150105382 MET gene Proteins 0.000 description 1
- 101000905241 Mus musculus Heart- and neural crest derivatives-expressed protein 1 Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000010807 real-time PCR kit Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510566302.XA CN105087570B (zh) | 2015-09-07 | 2015-09-07 | 一种环状rna人工过表达框架及其表达载体及构建方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510566302.XA CN105087570B (zh) | 2015-09-07 | 2015-09-07 | 一种环状rna人工过表达框架及其表达载体及构建方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105087570A CN105087570A (zh) | 2015-11-25 |
CN105087570B true CN105087570B (zh) | 2016-11-09 |
Family
ID=54568904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510566302.XA Active CN105087570B (zh) | 2015-09-07 | 2015-09-07 | 一种环状rna人工过表达框架及其表达载体及构建方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105087570B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105755042B (zh) * | 2016-03-25 | 2019-03-05 | 广州吉赛生物科技股份有限公司 | 筛选鉴定环状rna翻译蛋白质的荧光报告系统及其构建方法 |
CN106318976A (zh) * | 2016-09-14 | 2017-01-11 | 广州伯信生物科技有限公司 | 一种人类circRNA过表达载体框架、过表达载体及其制备方法 |
CN107058360B (zh) * | 2017-04-04 | 2019-03-01 | 河北医科大学第二医院 | 一种基于快速克隆技术的环状rna表达载体构建方法及其应用 |
CN108085331B (zh) * | 2017-12-26 | 2021-06-25 | 浙江自贸区锐赛生物医药科技有限公司 | 用于环状rna过表达的dna框架及其应用 |
CN108165549B (zh) * | 2017-12-26 | 2021-06-29 | 浙江自贸区锐赛生物医药科技有限公司 | 人工环状rna的通用表达框架及其应用 |
CN109355290B (zh) * | 2018-09-27 | 2021-12-14 | 四川农业大学 | 一种植物环状rna表达框架及其应用 |
CN111304195B (zh) * | 2020-03-06 | 2021-11-05 | 广州吉赛生物科技股份有限公司 | 一种低背景线性副产物的环形rna过表达框架及其构建方法 |
CN111701031B (zh) * | 2020-06-18 | 2023-04-28 | 中山大学孙逸仙纪念医院 | 靶向线粒体负载circRNA的纳米材料及其制备方法和应用 |
CN112574992A (zh) * | 2020-12-17 | 2021-03-30 | 湖南丰晖生物科技有限公司 | 一种circRNA过表达成环载体DNA序列及其构建方法与应用 |
CN113999849A (zh) * | 2021-11-04 | 2022-02-01 | 山东大学齐鲁医院 | 癌症生物分子标志物及应用 |
CN114807138B (zh) * | 2022-05-09 | 2023-07-25 | 华南农业大学 | 一种植物环状rna过表达载体及其构建方法和应用 |
CN116694666A (zh) * | 2023-07-07 | 2023-09-05 | 浙江大学 | 一种环形rna高效表达载体及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6625521B2 (ja) * | 2013-05-15 | 2020-01-08 | リボカイン,エルエルシー | 環状rnaの細胞内翻訳 |
CN104419704B (zh) * | 2013-09-05 | 2016-09-14 | 中国科学院上海生命科学研究院 | 一种内含子来源环形rna分子及其成环关键核酸序列的应用 |
-
2015
- 2015-09-07 CN CN201510566302.XA patent/CN105087570B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN105087570A (zh) | 2015-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105087570B (zh) | 一种环状rna人工过表达框架及其表达载体及构建方法 | |
Jost et al. | Functional sequestration of microRNA-122 from Hepatitis C Virus by circular RNA sponges | |
Osman et al. | Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes | |
CN105696088B (zh) | 一种双酶切简化基因组二代测序文库构建方法及配套试剂盒 | |
AU2017101108A4 (en) | Construction method of animal model of mucopolysaccharidosis type II and use thereof | |
CN108796086B (zh) | 一种环状RNAcircBCBM1及其非诊断性荧光定量检测方法 | |
CN102676677B (zh) | 一种microRNA定量检测方法 | |
CN107058360A (zh) | 一种基于快速克隆技术的环状rna表达载体构建方法及其应用 | |
CN105177132A (zh) | 一种定量检测miRNA的RT-PCR方法 | |
Ghetti et al. | CRISPR/Cas9 ribonucleoprotein-mediated knockin generation in hTERT-RPE1 cells | |
Zahm et al. | A high-content screen identifies microRNAs that regulate liver repopulation after injury in mice | |
CN102691111B (zh) | 高通量全基因组水平捕获染色质核小体空缺区的方法 | |
CN109355290A (zh) | 一种植物环状rna表达框架及其应用 | |
CN104232643B (zh) | RNAi干扰片段、干扰载体、制备方法及其应用 | |
Sandhu | Recombinant DNA technology | |
CN103740842B (zh) | 高灵敏度小rna定量检测方法及试剂盒 | |
CN116814740A (zh) | 检测甲状腺癌分子分型相关基因突变的文库构建方法 | |
CN110499334A (zh) | CRISPR/SlugCas9基因编辑系统及其应用 | |
CN105986020A (zh) | 构建测序文库的方法及装置 | |
CN103194441A (zh) | 获取miRNA候选靶基因的方法及其专用反转录引物 | |
CN114875033A (zh) | sgRNA、CRISPR/Cas试剂及其应用 | |
CN103789447A (zh) | 一种5’端tRNA半分子检测方法 | |
CN104630222B (zh) | 一种miRNA及对其进行检测的特异性引物和方法 | |
CN102465178B (zh) | 一种cot-1DNA、其制备方法及用途 | |
CN112126648A (zh) | 一种环状RNA circ_029155及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 510663 Guangdong province Guangzhou Science City skim Springs Road No. 3, Guangzhou International Incubator area D 706 Patentee after: Guangzhou bio Polytron Technologies Inc Address before: 510663 Guangdong province Guangzhou Science City skim Springs Road No. 3, Guangzhou International Incubator area D 706 Patentee before: Guangzhou Geneseed Biotech Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Annular RNA artificial over-expression frame as well as expression vector and construction method thereof Effective date of registration: 20181129 Granted publication date: 20161109 Pledgee: Guangzhou Caold financing Company limited by guarantee Pledgor: Guangzhou bio Polytron Technologies Inc Registration number: 2018440000342 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200615 Granted publication date: 20161109 Pledgee: Guangzhou Caold financing Company limited by guarantee Pledgor: Guangzhou bio Polytron Technologies Inc. Registration number: 2018440000342 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Annular RNA artificial over-expression frame as well as expression vector and construction method thereof Effective date of registration: 20200628 Granted publication date: 20161109 Pledgee: Development Zone sub branch of Bank of Guangzhou Co.,Ltd. Pledgor: Guangzhou bio Polytron Technologies Inc. Registration number: Y2020980003488 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210722 Granted publication date: 20161109 Pledgee: Development Zone sub branch of Bank of Guangzhou Co.,Ltd. Pledgor: Guangzhou bio Polytron Technologies Inc. Registration number: Y2020980003488 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Circular RNA artificial overexpression framework, expression vector and construction method thereof Effective date of registration: 20220112 Granted publication date: 20161109 Pledgee: Bank of Guangzhou branch of the Bank of Guangzhou Science City Branch Pledgor: Guangzhou bio Polytron Technologies Inc. Registration number: Y2022980000391 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |